Search the Newsreel

IDEXX Laboratories 2026: Revenue $1.22B, EPS $4.27— 10-Q Summary

IDEXX Laboratories reported strong financial results for the quarter ended 2026, with revenue of $1.22 billion and diluted EPS of $4.27, both exceeding the prior year. The growth was driven by higher volumes and prices in core segments, particularly recurring diagnostics and reference lab …

Nexxen International (NEXN) Projected to Release Quarterly Earnings on Wednesday

Nexxen International (NEXN) is scheduled to release its Q2 2026 earnings on Wednesday, August 12th, with analysts anticipating earnings of $0.17 per share and revenue of $92.8 million. The stock is currently trading near its 12-month high, demonstrating positive momentum above its moving averages, …

Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792

Jefferies has increased its price target for IDEXX Laboratories (IDXX) to $795 from the previous $792, while maintaining a Hold rating on the stock. This adjustment reflects a modest change in the firm's outlook for the company.

Citigroup Adjusts Price Target on IDEXX Laboratories to $670 From $650

Citigroup has raised its price target for IDEXX Laboratories (IDXX) from $650 to $670, as reported on August 5, 2026. This adjustment follows other recent analyst updates for the company, including Jefferies increasing its target to $795 and UBS raising its target to $670. …

UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670

UBS has reiterated its Hold rating on IDEXX Laboratories Inc (IDXX.US) and increased its price target to $670. This adjustment reflects the firm's updated valuation for the company.

Trump rips Exxon, Chevron for ‘making too much money’ as US gas prices soar above $4 — but is Big Oil the bad guy?

Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. President Donald Trump has long portrayed himself as a champion of free markets, domestic energy production and corporate America. But after some of the country's largest oil companies …

Avior Wealth Management LLC Sells 9,934 Shares of ExxonMobil Corporation $XOM

Avior Wealth Management LLC reduced its stake in ExxonMobil Corporation (NYSE:XOM) by 15.5% in the second quarter, selling 9,934 shares and retaining 53,996 shares valued at approximately $7.38 million. ExxonMobil reported strong quarterly revenue of $114.53 billion but narrowly missed earnings per share estimates …

Exxon Mobil Corp (XOM) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

IDEXX Laboratories, Inc. Stock 12‑Month Price Target Raised to $719, Implies 27% Upside

Analysts have raised the average 12-month price target for IDEXX Laboratories, Inc. (IDXX) stock to $719, up from $711.64, with a range between $620 and $805. This new target suggests a potential upside of approximately 27% from its Aug. 3 closing price. The consensus …

ExxonMobil Holdings (XOM) Could Be 9% Undervalued On Strong Q2 Earnings

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. ExxonMobil Holdings (XOM) has moved into the spotlight after reporting second quarter 2026 earnings that reflect strong oil prices, record refining margins and …

IDEXX (IDXX) Stock Rewards Margin Strength And Recurring Diagnostics Growth

William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating

William Blair has reiterated its Buy rating on IDEXX Laboratories Inc (IDXX.US). This continued endorsement reflects a positive outlook from the firm regarding the company's performance and prospects.

Trump slams Exxon, Chevron for profits amid war

Former President Donald Trump criticized ExxonMobil and Chevron for their substantial profits, urging them to lower retail petrol prices and give back to the public. The oil companies reported combined profits of US$29 billion in the second quarter, more than triple the previous year, …

IDEXX Laboratories (NASDAQ: IDXX) lifts Q2 2026 profit and cash flow

IDEXX Laboratories jumps 5% on strong results, raised guidance (IDXX:NASDAQ)

IDEXX Laboratories (IDXX) shares rose over 5% after the company reported strong second-quarter results and provided upbeat full-year earnings guidance. The veterinary diagnostics company posted an adjusted EPS of $4.07 for the quarter. This positive performance has led to a significant increase in its …

Exxon Posts Its Best Profit in Four Years, Here’s Where It’ll End The Year

Quick Read Exxon beat Q1 EPS by 15% and recorded its strongest underlying earnings in four years, but our $140 price target signals 9% downside. Chevron's trailing P/E of 19 versus Exxon's 26, and ConocoPhillips' lower PEG, make both peers look cheaper per unit …

Why Trump Has Blasted ExxonMobil (NYSE: XOM) And Chevron (NYSE: CVX) Over "Too Much Money"

President Donald Trump has publicly criticized ExxonMobil and Chevron for their excessive profits during the ongoing U.S.-led war against Iran. He called on the companies to reduce retail gasoline prices, arguing they are making "too much money" amid national strain. This rebuke comes as …

IDEXX Laboratories Q2 2026 Earnings Call Transcript

IDEXX Laboratories reported strong Q2 2026 financial results, with a 10% revenue increase and a raised full-year outlook. The company highlighted robust growth in CAG Diagnostics, Water, and LPD businesses, driven by innovation, increased diagnostic utilization, and expanding customer

IDEXX Laboratories Announces Second Quarter Results

IDEXX Laboratories reported strong second quarter 2026 results, with revenue growth of 10% and EPS increasing by 18%. The company's Companion Animal Group Diagnostics recurring revenue grew by 11%, driven by innovation and increased diagnostic utilization. IDEXX also narrowed its 2026 revenue guidance and …

Trump demands Exxon, Chevron cut gas prices after Iran war profits

President Donald Trump on Monday demanded that ExxonMobil and Chevron cut retail gasoline prices after the two companies reported windfall profits tied to the war in Iran. "They're making too much money based on a shortage," Trump told reporters at the White House. "I …

Exxon begins drilling new exploration well offshore Guyana (XOM:NYSE)

Exxon Mobil (XOM) has commenced drilling a new exploration well, Rockhead-1, offshore Guyana. This initiative is part of the company's ongoing efforts to uncover additional resources within the highly productive Stabroek block. This move highlights Exxon's continued investment and focus on expanding its oil …

Chevron, Exxon Making Too Much From Surging Oil, Trump Says. BP Profit More Than Doubles.

BP stock was edging higher after the British oil major reported a surge in its second-quarter profit, just a day after President Donald Trump slammed rivals Chevron and ExxonMobil for making too much money. BP’s American depositary receipts ticked up 0.7% to $44.57 ahead …

Idexx Laboratories (IDXX) Q2 Earnings and Revenues Top Estimates

Idexx Laboratories (IDXX) reported strong Q2 2026 earnings, beating Zacks Consensus Estimates for both earnings per share ($4.27 vs. $3.95) and revenues ($1.22 billion vs. $1.20 billion). The company has consistently surpassed analyst expectations over the past four quarters. Despite the positive results, Idexx …

IDEXX Labs earnings beat by $0.31, revenue topped estimates

IDEXX Labs (NASDAQ: IDXX) reported strong Q2 results, with EPS of $4.27 surpassing analyst estimates by $0.31 and revenue reaching $1.22 billion, exceeding the consensus. The company also provided optimistic FY 2026 guidance, projecting EPS between $14.69 and $14.94 and revenue of $4.70 billion …

Earnings Flash (IDXX) IDEXX Laboratories Posts Q2 Adjusted EPS $4.07, vs. FactSet Est of $3.94

IDEXX Laboratories (IDXX) announced its Q2 adjusted earnings per share (EPS) of $4.07, surpassing the FactSet estimate of $3.94. The company also reported increased Q2 comparable earnings and revenue, and provided an updated 2026 outlook. IDEXX Laboratories is a global leader in diagnostic instruments …

Earnings Flash (IDXX) IDEXX Laboratories, Inc. Reports Q2 Revenue $1.22B, vs. FactSet Est of $1.20B

IDEXX Laboratories, Inc. (IDXX) reported strong second-quarter results, with revenue reaching $1.22 billion, surpassing FactSet's estimate of $1.20 billion. The company also announced adjusted EPS of $4.07, exceeding the FactSet estimate of $3.94. This positive earnings flash highlights IDEXX's continued growth in the medical …

IDEXX Labs stock rises nearly 4% on earnings beat and raised guidance

IDEXX Laboratories Inc. reported strong second-quarter results, exceeding analyst expectations for both adjusted EPS and revenue. The company also raised its full-year 2026 EPS guidance, leading to a nearly 4% rise in its stock during pre-market trading. Key drivers included the "Technology for Life" …

IDEXX Laboratories, Inc. (NASDAQ: IDXX) lifts 2026 outlook after strong Q2

CX Institutional Sells 11,353 Shares of ExxonMobil Corporation $XOM

CX Institutional significantly reduced its stake in ExxonMobil Corporation by 14.6% in the second quarter, selling 11,353 shares but still retaining 66,197 shares valued at $9.05 million. Despite missing EPS estimates slightly, ExxonMobil reported strong revenue, declared a $1.03 quarterly dividend, and maintains a …

Idexx (IDXX) Reports Q2 Earnings: What Key Metrics Have to Say

Update: IDEXX Laboratories' Q2 Earnings, Revenue Increase; 2026 Outlook Updated

IDXX Q2 Earnings & Revenues Beat, '26 EPS View Up, Stock Up in Pre-Market

IDEXX Laboratories Shares Climb After Earnings Beat and Improved Full-Year Outlook

Why Is IDEXX Laboratories Stock Gaining Tuesday?

IDEXX Laboratories (NASDAQ: IDXX) stock rose on Tuesday after the company reported strong second-quarter results that exceeded Wall Street estimates and subsequently raised its full-year earnings outlook for 2026. The growth was primarily driven by its Companion Animal Diagnostics segment, despite a slight decline …

IDEXX Laboratories Inc Stock Price Live, Charts & News

This article provides live stock information for IDEXX Laboratories Inc (IDXX), including its current share price, historical performance, and key financial metrics like market capitalization, PE ratio, and dividend yield. It also presents the company's balance sheet, income statement, and cash flow data up …

Trump calls out Exxon and Chevron for 'making too much money'

[Data analyzing in commodities energy market: the charts and quotes on display. US WTI crude oil price analysis. Stunning price drop for the last 20 years.] SlavkoSereda/iStock via Getty Images President Trump scolded [https://www.wsj.com/business/energy-oil/trump-blasts-big-oil-companies-for-making-too-much-money-e113c41b] Exxon Mobil (XOM [https://seekingalpha.com/symbol/XOM]) and Chevron (CVX [https://seekingalpha.com/symbol/CVX]) for their …